IUHSA
BHVN

Itau Unibanco Holding S.A.’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-88
Closed -$3.05K – 458
2024
Q2 		$3.05K Buy
+88
New +$3.05K ﹤0.01% 333
2019
Q4 		– Sell
-336
Closed -$15K – 1033
2019
Q3 		$15K Hold
336
– – ﹤0.01% 269
2019
Q2 		$15K Sell
336
-1,113
-77% -$62.7K ﹤0.01% 576
2019
Q1 		$51K Hold
1,449
– – ﹤0.01% 524
2018
Q4 		$51K Buy
1,449
+461
+47% +$16.6K ﹤0.01% 524
2018
Q3 		$37K Sell
988
-64
-6% -$2.35K ﹤0.01% 555
2018
Q2 		$41K Sell
1,052
-1,041
-50% -$33K ﹤0.01% 634
2018
Q1 		$54K Buy
2,093
+1,258
+151% +$37.6K ﹤0.01% 471
2017
Q4 		$22K Buy
835
+320
+62% +$8.81K ﹤0.01% 493
2017
Q3 		$61K Buy
+515
New +$15.6K ﹤0.01% 564

Other funds holding BHVN

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return

Itau Unibanco Holding S.A.'s BHVN Position: Q3 2024 in Review

Itau Unibanco Holding S.A. sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2024, closing a stake of 88 shares — an estimated $3.05K sold.

Itau Unibanco Holding S.A. first reported a position in BHVN in Q3 2017 and held it in 10 quarters. The position peaked at $61K in Q3 2017. 3 funds tracked by Wall St. Rank hold BHVN as of Q3 2024.

  • Itau Unibanco Holding S.A. reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 88 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2024, an estimated $3.05K.
  • Itau Unibanco Holding S.A. first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2017 and held it in 10 quarters.
  • Itau Unibanco Holding S.A.'s Biohaven Pharmaceutical Holding Company Ltd. position peaked at $61K in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2024, filed 14 Nov 2024.